Stock Summary

It operates through two segments, Cannabis, Hemp and Other Consumer Products; and Canopy Rivers. The company’s products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Bean & Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. canopy growth Corporation has a clinical research partnership with NEEKA Health Canada and NHL Alumni Association to examine the efficacy of CBD-based therapies as part of the mitigation of persistent post-concussion symptoms.

During the second quarter of 2021 (ended Sept. 30), revenue was up 77% year over year to CA$133.3 million. The marijuana producer’s margins also drastically improved, with gross margins jumping from 5% back in Q to 19%. It also lost CA$250 million less than last year, at a cash burn rate of CA$190.4 million per quarter. Strong revenue growth is the hallmark of success for these two blue-chip pot stocks. In November 2019, the company announced the release of retail edible cannabis products, including THC- and CBD-infused beverages and chocolates.

„Canopy Growth applies to become first pot producer listed on the NYSE“. Expansion into Europe continued in April 2019 with the acquisition of licensed cannabis producer Cáñamo y Fibras Naturales, S.L. By that time, the Company already owned a licensed production site in Odense, Denmark, as well as the Storz and Bickel facility in Tuttlingen, Germany. The board left Mark Zekulin to continue as sole CEO and a search was to be conducted for a replacement co-CEO. Rade Kovacevic was named President and John Bell was appointed chairman. In an interview, he told CNBC that he had been „terminated“, not „stepped down“ as previous reports had suggested.

Cronos is focusing its attention on bringing hemp-derived CBD oil, skincare products, and supplements to the U.S. if cannabis production and sale becomes federally legal in the United States — which they anticipate could happen within the next year. „Federal marijuana legislation approved by House of Commons, moves on to Senate“ – via The Globe and Mail. „Constellation Brands invests $5B to boost stake in pot producer Canopy Growth – The Star“. „First legal purchase of cannabis made in Newfoundland and Labrador“.

This company was supposed to turn into a titan of industry in the booming global cannabis market, with surging revenues, huge profits and a soaring stock price. We launched Quatreau RTD CBD beverages across Canada in the current quarter. To date, over 2.0 million beverage units have been shipped since late March 2020. Canopy Growth’s business-to-consumer model began with online medical sales directly to consumers.

Actual sales to casual users was likely to commence in January 2018. In January 2019, Canopy Growth announced that it was granted a license by New York State to process and produce hemp in the United States. President Bruce Linton said the additional funds would be used for international expansion wherever federal laws allow it. Future marketing plans include products such as cannabis-infused beverages and sleep aids. After the Constellation deal was announced, the market value of Canopy Growth rose to nearly US$12 billion. International cannabis revenue made up 24% of Canopy’s total cannabis revenues in the quarter, and oils and softgels accounted for more than 70% of the company’s global medical marijuana product mix. Fourth-quarter recreational sales were also hit by what Lee described as a phased rollout of so-called “cannabis 2.0” products such as vapes, edibles and beverages, which began hitting the market throughout the quarter.

Unfortunately, we can’t quite say the same about pot stocks to buy. Canopy Growth has a market capitalization of $8.82 billion and generates $297.34 million in revenue each year. The marijuana producer earns $-993,370,000.00 in net income each year or $1.32 on an earnings per share basis. Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands.

Analyst Ratings

Cronos Group and other cannabis stocks were falling on Nov. 4 after voters in New Jersey and Arizona passed measures that legalized recreational marijuana for adults age 21 and older due to Republicans potentially controlling the Senate. In its Q (ended Sept. 30) earnings release, Cronos doubled its revenue to more than $11 million from $5.8 million in Q2 2019. As with Canopy Growth, however, Cronos‘ upcoming expansion is largely baked into the stock price.

… We see a significant opportunity to recruit these intended consumers through products like our drinks,” CEO David Klein said. SectorIndustryMarket CapRevenue MedicalMedical Products Manufacturing$8.881B$0.297B Canopy Growth Corporation is a cannabis company. It offers dry cannabis and oil products primarily under the Tweed brand. The Canopy Growth 52-week low stock price is 9.00, which is 62.1% below the current share price.

Canopy Growth Fires Its Co

Interim CEO and co-founder Mark Zekulin was to step down before year end; Klein was to assume his new role on 14 January 2020. One news report stated that the appointment of Klein would further entrench Constellation’s influence on stock investment.

After rising 60 percentage points, shares fell 23 percentage points the week after the election and is now only up 11 percentage points since Election Day. For more in-depth coverage of the cannabis sector including buy and sell recommendations and investment strategies, follow Debra Borchardt on Real Money. Sign Up NowGet this delivered to your inbox, and more info about our products and services.

In technical analysis, accumulation can be equated to an asset’s bottom. It is usually the price range where the smart money scales in after a vicious bear market. At this point, the security has lost so much value that investors in the know think it is cheap enough to start buying shares. Spectrum Therapeutics sells a range of full-spectrum products using its colour-coded classification Spectrum system as well as single cannabinoid Dronabinol under the brand Bionorica Ethics. View our full suite of financial calendars and market data tables, all for free. uncovered interest arbitrage continues to leverage its bigger-than-peer production facilities, first-mover’s advantage, strong product line-up and even stronger partnerships to sustain leadership in this $60+ billion global cannabis market at scale.

International cannabis giant Corp. lost ground in Canada’s growing recreational marijuana market in its fourth quarter, with net revenue dropping 13% compared to the previous quarter. Stock splits are used by Canopy Growth Corporation to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. This is common when share prices drop below $1.00 and company’s become in danger of being delisted. However, because of the cost, stock splits are not a normal business occurrence. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis.

• In its Q (ended Sept. 30) earnings release, Cronos doubled its revenue to more than $11 million from $5.8 million in Q2 2019.
• However, net revenue in Q2 FY 2021 grew 76.6% to $135.3 million, primarily driven by growth in recreational-use cannabis sales.
• Cronos Group and other cannabis stocks were falling on Nov. 4 after voters in New Jersey and Arizona passed measures that legalized recreational marijuana for adults age 21 and older due to Republicans potentially controlling the Senate.
• Canopy Growth management has focused on a strategy of absorbing financial losses short term in order to dramatically expand its operations and sales in the emerging recreational and medical cannabis markets in the U.S, Canada, and globally.

To the best of the Company’s knowledge, this study represents the first long-term toxicity and lifespan research regarding the effects of chronic exposure to cannabidiol – one of the cannabinoids found in cannabis. Electronic retailing (e-tailing) is the sale of goods and services over the Internet, which can include B2B or B2C sales. Canopy Growth Corp. „Form 10-Q for the quarterly period ended June 30, 2020,“ Page 34. Canopy Growth Corp. „Form 10-Q for the quarterly period ended September 30, 2020,“ Page 38.

Market capitalization is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. As we approach the one-year anniversary of the Agriculture Improvement Act of 2018, or the “farm bill” as it’s better known, much has changed in the cannabis industry. With the bill de-scheduling industrial hemp and hemp-based derivatives, cannabis retail has flourished.

BioSteel signed distribution agreements with leading beverage distribution companies, Reyes Beer Division and Manhattan Beer, alongside several other partnerships through Constellation Brands’ distribution network. These distribution agreements will bring BioSteel’s ready-to-drink, electrolyte-packed sports hydration beverages to consumers, covering 100% of the US market through direct-store-delivery network by early 2021. BioSteel is currently in discussion with a number of large national accounts and expects to have products on shelf across Food/Drug/Mass as well as Convenience & Gas channel over the course of calendar year 2021. Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. By IBD’s typical yardsticks, Canopy Growth stock is not a buy as it is extended out of a buy range and profits are still elusive. However, investors who accept the risks and are nonetheless eager to get into marijuana stocks could buy Canopy, based purely on its chart pattern, once it is in a buy zone.

Instead, CBD extended mean lifespan up to 18% and increased late-stage life activity by up to 206% compared to the untreated controls within the study. The study was commissioned to evaluate the solubility, stability, acute toxicity, thermotolerance, and effects on lifespan of CBD in C. elegans as part of Canopy Growth’s ongoing commitment to provide the data required to support and influence public policy through research.

Adjusted EBITDA is a non-GAAP measure used by management that is not defined by U.S. GAAP and may not be comparable to similar measures presented by other companies. The Adjusted EBITDA reconciliation is presented within this news release and explained in the Company’s Quarterly Report on Form 10-Q to be filed with the SEC. Canopy Growth’s business-to-business wholesale model was developed in response to the legalization of recreational cannabis in Canada, as the existing medical cannabis market was largely based on a business-to-consumer model. The business-to-business wholesale model sells large quantities of cannabis to provincial and territorial agencies, which then distribute the product to physical and online retail stores. Cannabis stocks have come back into the picture after the 2020 election. Joe Biden also beat Donald Trump in the presidential race giving cannabis investors more hope.